The anti-idiotypic antibody 1F7 selectively inhibits cytotoxic T cells activated in HIV-1 infection

Immunology and Cell Biology

Volumn 78, Issue 1, 2000, Pages 20-27

  Grant, Michael ^a,e   Smaill, Fiona ^b   Muller, Sybille ^c,f   Kohler, Heinz ^c   Rosenthal, Kenneth ^d  

^a Immune Network Research Limited   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c UNIVERSITY OF KENTUCKY   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^f Immpheron Incorporated   (United States)

Author keywords

Anti idiotypic antibody; Cytotoxic T lymphocyte; Human immunodeficiency virus 1

Indexed keywords

ALLOANTIGEN; ANTIIDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NATURAL KILLER CELL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033980539     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00879.x     Document Type: Article

References (32)

1. + T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J. Virol. 1991; 65: 2019-23.
2. + T lymphocytes and progression to AIDS in HIV-infected men: Some observations. AIDS 1991; 5: 213-15.
3. 3 Polk BF, Fox R, Brookmeyer R et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of sero-positive homosexual men. N. Engl. J. Med. 1987; 316: 61-6.
4. + cells. J. Immunol. 1990; 144: 2992-8.
5. + lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals. Clin. Exp. Immunol. 1993; 93: 356-62.
6. 6 Grant MD, Whaley MD, Mayne A, Hoffmann GW, Ansari AA. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV) -infected macaques. Immunol. Cell Biol. 1996; 74: 38-44.
7. + lymphocyte depletion in HIV-1 infection. J. Acquir. Immune Defic. Syndr. 1994; 7: 571-9.
8. 8 Kottilil S, Bowmer MI, Trahey J, Campbell C, Gallant M, Grant MD. The relationship between circulating autoreactive cytotoxic T lymphocyte activity and stage of disease in HIV infection. Can. J. Infect. Dis. 1997; 8SA: A62.
9. 9 Zinkernagel RM, Hengartner H. T-cell-mediated immunopathology versus direct cytolysis by virus; implications for HIV and AIDS. Immunol. Today 1994; 15: 262-8.
10. 10 Adleman LM, Wofsy D. T-cell homeostasis: Implications in HIV infection. J. Acquir. Immune Defic. Syndr. 1993; 6: 144-52.
11. - populations suggest regulatory responses linked to loss of CD4 lymphocytes. J. Acquir. Immune Defic. Syndr. 1993; 6: 153-61.
12. 12 Andrieu JM, Even P, Venet A et al. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin. Immunol. Immunopathol. 1988; 47: 181-98.
13. + lymphocyte count in non-progressors and progressors towards AIDS. Clin. Exp. Immunol. 1990; 81: 177-82.
14. 14 Kovacs JA, Baseler M, Dewar RJ et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection - A preliminary study. N. Engl. J. Med. 1995; 332: 567-72.
15. 15 Müller S, Wang H-T, Kaveri S-V, Chattopadhyay S, Köhler H. Generation and specificity of monoclonal anti-idiotypic antibodies against human HIV-specific antibodies. J. Immunol. 1991; 147: 933-41.
16. 16 Müller S, Wang H, Silverman GJ, Bramlet G, Haigwood N, Köhler H. B-cell abnormalities in AIDS. Stable and clonally restricted antibody response in HIV-1 infection. Scand. J. Immunol. 1993; 38: 327-34.
17. 17 Müller S, Margolin DH, Nara PL, Alvord WG, Köhler H. Stimulation of HIV neutralizing antibodies in simian HIV-IIIB-infected macaques. Proc. Natl Acad. Sci. USA 1998; 95: 276-81.
18. + Cells from HIV-1 infected individuals: role of anti-idiotypic antibodies. Vaccine Res. 1995; 4: 229-38.
19. 19 Flexner C, Broyles SS, Earl P, Chakrabarti S, Moss B. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses. Virology 1988; 166: 339-49.
20. 20 Walker BD, Flexner C, Paradis TJ, Fuller TC, Hirsch MS, Schooley RT. HIV-1 reverse transcriptase as a target for cytotoxic T-lymphocytes in infected individuals. Science 1988; 240: 64-6.
21. 21 Chakrabarti S, Robert-Guroff M, Wong-Staal F, Gallo RC, Moss B. Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature 1986; 320: 535-7.
22. 22 Fontana L, Sirianni MC, De Sanctis G, Carbonari M, Ensoli B, Aiuti F. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphadenopathy syndrome positive for antibodies to HTLV-III. Immunobiology 1986; 171: 425-35.
23. 23 Wang H-T, Müller S, Zolla-Pazner S, Köhler H. Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity. Eur. J. Immunol. 1992; 22: 1749-55.
24. 24 Pereira P, Bandeira A, Coutinho A. V-region connectivity in T cell repertoires. Annu. Rev. Immunol. 1989; 7: 209-49.
25. 25 Zhou S, Whitaker JN, Han Q, Maier C, Blalock JE. A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR Vβ8.2. J. Immunol. 1994; 153: 2340-51.
26. 26 Janson CH, Grunewald J, Osterborg A et al. Predominant T cell receptor V gene usage in patients with abnormal clones of B cells. Blood 1991; 77: 1776-80.
27. 27 Amadori A, Gallo P, Zamarchi R et al. IgG oligoclonal bands in sera of HIV-1-infected patients are mainly directed against HIV-1 determinants. AIDS Res. Hum. Retroviruses 1990; 6: 581-6.
28. 28 Grant MD, Smaill FM, Laurie K, Rosenthal KL. Changes in the cytotoxic T-cell repertoire of HIV-1-infected individuals: Relationship to disease progression. Viral Immunol. 1993; 6: 85-95.
29. 29 Pantaleo G, Demarest JF, Shacker T et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl Acad. Sci. USA 1997; 94: 254-8.
30. 30 Morimoto C, Rudd CE, Letvin NL, Schlossmann SF. A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells. Nature 1987; 330: 479-83.
31. 31 Allen AD, Mathisen GE, Glover N, Au J. HIV and AIDS. Science 1993; 260: 1706-7.
32. 32 Perricone R, Fontana L, DeCarolis C, Carini C, Sirianni MC, Ainiti F. Evidence for activation of complement in patients with AIDS-related complex (ARC) and or lymphadenopathy syndrome (LAS). Clin. Exp. Immunol. 1987; 70: 500-7.